These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22326459)

  • 1. Toll-like receptor signaling: a perspective to develop vaccine against leishmaniasis.
    Singh RK; Srivastava A; Singh N
    Microbiol Res; 2012 Sep; 167(8):445-51. PubMed ID: 22326459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.
    Doroud D; Rafati S
    Expert Rev Vaccines; 2012 Jan; 11(1):69-86. PubMed ID: 22149710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NF-κB activation during protection against Leishmania infection.
    Reinhard K; Huber M; Lohoff M; Visekruna A
    Int J Med Microbiol; 2012 Oct; 302(4-5):230-5. PubMed ID: 22901377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The investigations of the role of toll-like receptors (TLR) in host response to parasitic infection on the current background regarding TLR in mammals and the model nematode Caenorhabditis elegans].
    Wojtkowiak A
    Wiad Parazytol; 2007; 53(3):203-11. PubMed ID: 18075152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant and regulatory roles for Toll-like receptors in Leishmania infection.
    Chauhan P; Shukla D; Chattopadhyay D; Saha B
    Clin Exp Immunol; 2017 Nov; 190(2):167-186. PubMed ID: 28708252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
    Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
    Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying vaccine targets for anti-leishmanial vaccine development.
    Sundar S; Singh B
    Expert Rev Vaccines; 2014 Apr; 13(4):489-505. PubMed ID: 24606556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.
    Banerjee A; Bhattacharya P; Joshi AB; Ismail N; Dey R; Nakhasi HL
    Cell Immunol; 2016 Nov; 309():37-41. PubMed ID: 27444130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate immune response against Leishmania parasites.
    Liese J; Schleicher U; Bogdan C
    Immunobiology; 2008; 213(3-4):377-87. PubMed ID: 18406382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.